![a Black man wearing goggles and other protective medical equipment in a research laboratory working with viles and tubes](https://newsnetwork.mayoclinic.org/n7-mcnn/7bcc9724adf7b803/uploads/2020/09/a-Black-man-wearing-goggles-and-other-protective-medical-equipment-in-a-research-laboratory-working-with-viles-and-tubes-16x9-1-1024x576.jpg)
While the number of COVID-19 cases continues to surge, there is positive news on the vaccine front. In early clinical trial data, two vaccines have now shown at least 90% effectiveness in reducing the risk of infection from the virus that causes COVID-19. While more time and research is needed to understand how long the immunity from a vaccine lasts, experts believe a vaccine could be approved for emergency use authorization before the end of the year.
On the Mayo Clinic Q&A podcast, Dr. Gregory Poland, an infectious diseases expert and head of Mayo Clinic's Vaccine Research Group, discusses the latest on current COVID-19 clinical trials. Dr. Poland also explains what public health experts mean by community spread of the virus and why that leads to exponential growth in cases of COVID-19.
Research disclosures for Dr. Gregory Poland.
Information in this post was accurate at the time of its posting. Due to the fluid nature of the COVID-19 pandemic, scientific understanding, along with guidelines and recommendations, may have changed since the original publication date.
For more information and all your COVID-19 coverage, go to the Mayo Clinic News Network and mayoclinic.org.
![](https://newsnetwork.mayoclinic.org/n7-mcnn/7bcc9724adf7b803/uploads/2019/10/MC-QA_1400x1400-300x300.jpg)
Related Articles
![](https://newsnetwork.mayoclinic.org/n7-mcnn/7bcc9724adf7b803/uploads/2024/06/clinical-trialist-story1x1.jpg)
![](https://newsnetwork.mayoclinic.org/n7-mcnn/7bcc9724adf7b803/uploads/2024/05/Dr_Rutter_at_electurn-1x1-1.jpg)